Integrative molecular analyses of the MD Anderson prostate cancer patient-derived xenograft (MDA PCa PDX) series.
Anselmino N, Labanca E, Shepherd PDA, Dong J, Yang J, Song X, Nandakumar S, Kundra R, Lee CJ, Schultz N, Zhang J, Araujo JC, Aparicio AM, Subudhi SK, Corn PG, Pisters LL, Ward JF, Davis JW, Vazquez ES, Gueron G, Logothetis CJ, Futreal A, Troncoso P, Chen Y, Navone NM.
Anselmino N, et al. Among authors: davis jw.
Clin Cancer Res. 2024 Mar 15. doi: 10.1158/1078-0432.CCR-23-2438. Online ahead of print.
Clin Cancer Res. 2024.
PMID: 38488813